BioLargo Generates Positive Operating Cash Flow on Record Quarterly Revenues for First Quarter of 2024

Stock Information for Biolargo Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Biolargo Inc

BioLargo Engineering Increases Ongoing Revenue with Another Air Force Contract
BioLargo Subsidiary Clyra Medical Selects Keystone Industries to Support Manufacturing of its Medical Products
BioLargo Manufactures First Cellinity Battery Cells, a Safer Alternative to Lithium-ion
BioLargo Engineering Secures Multi-Year Air Force Base Air Compliance Project
OTC Markets Group Welcomes BioLargo, Inc. to OTCQX
BioLargo Q1 2024 Earnings Results Webcast and Conference Call on Tuesday, May 14, 2024 - 5:30 PM Eastern Time
EPA Adds PFAS to CERCLA (Superfund) Law, Favoring Low-Waste Systems like BioLargo's AEC
BioLargo PFAS Removal Technology Meets New US Drinking Water Standards

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.